Establishment of homogeneous time-resolved fluorescence immunoassay for high throughput screening of protein tyrosine kinase inhibitors.
- Author:
Xu-gui LI
1
;
Guang-fa WANG
;
Jun-yan ZHANG
;
Shao-yu WU
;
Wei XU
;
Shu-guang WU
;
Jia-jie ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Fluoroimmunoassay; methods; High-Throughput Screening Assays; methods; Indoles; pharmacology; Peptides; metabolism; Phosphorylation; drug effects; Protein Kinase Inhibitors; pharmacology; Protein-Tyrosine Kinases; antagonists & inhibitors; metabolism; Pyrroles; pharmacology; Time Factors; Vascular Endothelial Growth Factor Receptor-2; antagonists & inhibitors; metabolism
- From: Journal of Southern Medical University 2009;29(8):1612-1614
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo establish an in vitro homogeneous time-resolved fluorescence immunoassay method for high throughput screening of protein tyrosine kinase (PTK) inhibitors.
METHODSSpecific fluorescence signals at 670 and 612 nm were measured by multifunctional microplate reader when the fluorescence was emitted through a resonance energy transfer between fluorescent materials (EuK and XL-665). The inhibitory activity of Sunitinib, a standard PTK inhibitor, on vascular endothelia growth factor receptor 2 (VEGFR-2) kinase activity was investigated.
RESULTSA homogeneous time-resolved fluorescence immunoassay was established for high throughput screening of PTK inhibitor. In this system, the concentrations of VEGFR-2, adenosine triphosphate (ATP) and poly-peptide substrate were 5 ng/microl, 100 micromol/L and 1 micromol/L, respectively. Sunitinib inhibited VEGFR-2 kinase activity with an IC50 value of 86.7 nmol/L, which was close to the values tested using other methods.
CONCLUSIONThe homogeneous time-resolved fluorescence immunoassay we established can be easily used for high throughput screening of PTK inhibitors.